Press release
New Research Report On Noninvasive Cancer Diagnostics Market Growth And Trends - Top Key Companies: Roche Diagnostics, Hologic, Qiagen, Gen-Probe, Digene Corporation, Abbott Molecular, IVDiagnostics, OncoCyte Corporation, Archer Diagnostics, and Affymetri
The Global Noninvasive Cancer Diagnostics Market is estimated to grow from nearly USD 114.6 billion in 2017 to USD 159.8 billion by 2022 with a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Global Noninvasive Cancer Diagnostics Market Overview:
Non-invasive diagnosis is a procedure to identify a disease without or with a minimal incision of the body. These methods involve different techniques, such as the identification of genetic structure, biomarkers, changes in molecular biology, as well as imaging technologies. Cancer is a disease related to a genetic alteration of cells, which causes uncontrolled growth and the formation of a structure like a tumor. The images are the preferred method to detect cancer but cannot have genetic access. On the other hand, biopsies with genetic access are complicated and difficult to perform repeatedly during cancer diagnosis and therapy. Therefore, newer techniques were developed in the context of non-invasive diagnostics, such as molecular diagnostics, serum immunoassays and chemical tests to identify chemical components in the body, especially blood and urine. All these procedures are performed with either non-surgical or minimal surgical procedures; As a result, these non-invasive cancer diagnostic techniques are becoming increasingly popular among health professionals. According to Cancer Research UK, no diagnostic test is currently 100% accurate in general practice. This suggests the unmet demand for a new, more effective diagnostic test. The effectiveness of molecular diagnostics for the detection of blood and tissue samples for the detection of cancer drives the research and development of a molecular diagnostic method based on biomarkers capable of detecting abnormalities early in life. Development cycle in addition, according to the Genome Biology article published in 2017, current research on non-invasive cancer detection points to two kinds of studies: the development of biomarkers for a specific type of cancer and the characterization of circulating tumor DNA for the general detection of cancer. These studies will help manufacturers develop better cancer detection kits for molecular diagnostics.
Get Sample Brochure of the Report @ https://www.researchcosmos.com/request/global-noninvasive-cancer-diagnostics-market-analysis-with-f/1666538539
Drivers and restrictions:
The increase in product launches as part of organic strategies to dominate the market is also the key factor for the growth of the non-invasive cancer diagnostic market. In addition, technologies such as spectroscopy should be an alternative for liquid biopsy. It is also expected that the increase in pipeline products will boost the market growth. In addition, in 2016, Exosome Diagnostics, Inc. launched the ExoDx Prostate (IntelliScore) test. The test uses genetic information from a urine sample to assess the risk of high-grade prostate cancer in the patient. Laboratory Corporation of America Holdings, in 2016, launched Epi ProColon, the first DNA-based blood test approved by the FDA for screening the colorectal cancer with the approval of the FDA. The inorganic strategies of market agents continue to stimulate the market for the diagnosis of non-invasive cancer. For example, in 2017, Lonza, a biopharmaceutical development and manufacturing company, acquired HanaBioMed Life Sciences OR, a company dedicated to the research and development, manufacture and distribution of products for the genome market. With this acquisition, the company will invest in the development of early cancer detection tests and molecular tests based on exosomes. In the same year, CORE Diagnostics partnered with CellMax Life to present the CellMax cancer genetic risk test and the cDNA-based liquid biopsy throughout India.
Geographic Segmentation:
Based on geography, Global Noninvasive Cancer Diagnostics Market has been divided into areas like Europe, North America, and Asia-pacific, Latin America, Middle East and Africa. North America has been dominating the international market, followed by Europe. The main companies of Global Noninvasive Cancer Diagnostics Market are Roche Diagnostics, Hologic Inc., Qiagen, Gen-Probe Inc., Digene Corporation, abbott Molecular, IVDiagnostics, Laboratory Corporation of America Holdings, OncoCyte Corporation, Arquer Diagnostics Ltd. and Affymetrix Inc.
Browse report brief and TOC @ https://www.researchcosmos.com/reports/global-noninvasive-cancer-diagnostics-market-analysis-with-forecasts-to-2022-growth-opportunities/1666538539
Scope of the report:
The report offers a comprehensive analysis of the industry by providing the estimations of market potential and forecasts with utmost granularity. Along this, the factors influential in effecting the market dynamics and trends are discussed in detail at the product level. Further, the performance of the market at the regional and country-level is assessed and the prospects with high growth potential are identified and debated.
The key players in the industry are profiled providing insights on their financial performance, market position and growth strategies. Comparative analysis on prime strategical activities of the market players delineating the key developments like mergers & acquisitions, collaborations and an evaluation of the competitive environment within the industry are provided. The report also offers a broad outlook of the market along with recommendations from industry experts on the opportunities for investment activity.
What else? Apart from the syndicated report, our in-house team has an expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.
Inquire Before Buying @ https://www.researchcosmos.com/inquire/global-noninvasive-cancer-diagnostics-market-analysis-with-f/1666538539
About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/
kevin@researchcosmos.com
+1 888 709 8757
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Research Report On Noninvasive Cancer Diagnostics Market Growth And Trends - Top Key Companies: Roche Diagnostics, Hologic, Qiagen, Gen-Probe, Digene Corporation, Abbott Molecular, IVDiagnostics, OncoCyte Corporation, Archer Diagnostics, and Affymetri here
News-ID: 1262485 • Views: …
More Releases from Research Cosmos
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking.
Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834
Growing utilization…
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview:
Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period.
Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of…
More Releases for Diagnostics
Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate…
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025.
The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact…
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster…
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get Free Sample PDF Copy at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3095138.
Top Key Players in the Global Covid-19 Diagnostic Market Include: -
o Abbott Diagnostics
o …
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments
The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer…
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report.
Get Sample Copy of this Report @…
